Aisling Capital Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,043,267
| Closed | -$10M | – | 15 |
|
|
2024
Q4 | $10M | Hold |
1,043,267
| – | – | 3.55% | 5 |
|
|
2024
Q3 | $2.98M | Hold |
1,043,267
| – | – | 1.14% | 9 |
|
|
2024
Q2 | $3.05M | Hold |
1,043,267
| – | – | 1.32% | 9 |
|
|
2024
Q1 | $3.33M | Hold |
1,043,267
| – | – | 1.13% | 9 |
|
|
2023
Q4 | $3.51M | Hold |
1,043,267
| – | – | 1.05% | 9 |
|
|
2023
Q3 | $2.48M | Hold |
1,043,267
| – | – | 1.02% | 11 |
|
|
2023
Q2 | $1.84M | Hold |
1,043,267
| – | – | 0.9% | 11 |
|
|
2023
Q1 | $3.21M | Hold |
1,043,267
| – | – | 1.55% | 10 |
|
|
2022
Q4 | $5.53M | Hold |
1,043,267
| – | – | 3.65% | 7 |
|
|
2022
Q3 | $3.68M | Hold |
1,043,267
| – | – | 2.45% | 8 |
|
|
2022
Q2 | $2.69M | Hold |
1,043,267
| – | – | 1.92% | 10 |
|
|
2022
Q1 | $4.67M | Hold |
1,043,267
| – | – | 2.52% | 10 |
|
|
2021
Q4 | $7.11M | Hold |
1,043,267
| – | – | 2.51% | 12 |
|
|
2021
Q3 | $7.61M | Hold |
1,043,267
| – | – | 1.52% | 11 |
|
|
2021
Q2 | $10.5M | Hold |
1,043,267
| – | – | 1.67% | 11 |
|
|
2021
Q1 | $9.96M | Hold |
1,043,267
| – | – | 1.79% | 10 |
|
|
2020
Q4 | $11.4M | Hold |
1,043,267
| – | – | 1.97% | 8 |
|
|
2020
Q3 | $9.25M | Buy |
+1,043,267
| New | +$9.25M | 2.96% | 7 |
|